Intragastric Balloon Market Size & Share, By Balloon Type (Single, Dual, Triple), Filling Material (Saline Filled, Gas Filled), Administration (Endoscopy, Pill Form), End-use (Hospitals, Ambulatory Centers), Regional Forecast, Industry Players, Growth Statistics Report 2024-2032

Market Outlook:

Intragastric Balloon Market crossed USD 45.45 Million in 2023 and is estimated to reach USD 101.18 Million by end of the year 2032, growing at over 9.3% CAGR between 2024 and 2032.

• Base Year Value (2023): USD 45.45 Million
• CAGR (2024-2032): 9.3%
• Forecast Year Value (2032): USD 101.18 Million
• Historical Data Period: 2019-2023
• Largest Region: North America
• Forecast Period: 2024-2032

Market Dynamics:

Growth Drivers & Opportunity:

The increasing prevalence of obesity worldwide is driving the growth of the intragastric balloon market. Obesity is a major risk factor for various chronic diseases, including diabetes, cardiovascular diseases, and certain types of cancer, creating a strong demand for non-surgical weight loss solutions such as intragastric balloons. The rising awareness about the health risks associated with obesity and the importance of weight management is also contributing to the market growth.

Another major growth driver for the intragastric balloon market is the technological advancements in intragastric balloon devices. Manufacturers are constantly innovating to improve the safety and efficacy of intragastric balloons, leading to the development of advanced balloon designs with better durability and patient comfort. These technological advancements are attracting more patients towards intragastric balloon procedures and expanding the market size.

The growing preference for minimally invasive weight loss procedures is also fueling the growth of the intragastric balloon market. Intragastric balloon placement is a less invasive alternative to bariatric surgery, offering a shorter recovery time, lower risk of complications, and reversible weight loss outcomes. As patients increasingly seek less invasive weight loss options, the demand for intragastric balloons is expected to continue rising.

Report Scope

Report Coverage	Details
Segments Covered	Balloon Type, Filling Material, Administration, End-use
Regions Covered	• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company Profiled	Allurion Technologies, Allergan, Apollo Endosurgery, Reshape Medical, Spatz FGIA, Endalis, Silimed, Medsil

Industry Restraints:

However, despite the growth drivers, there are also some restraints impacting the intragastric balloon market. A significant restraint is the high cost of intragastric balloon procedures. The cost of intragastric balloon placement can be a barrier for many patients, especially in regions with limited insurance coverage for weight loss interventions. The high out-of-pocket expenses associated with intragastric balloons can limit the market penetration and adoption rates.

Moreover, a significant restraint for the intragastric balloon market is the potential side effects and complications associated with the procedure. While intragastric balloons are generally considered safe, there are risks of adverse events such as gastric ulceration, migration, and bowel obstruction. The occurrence of these complications, although rare, can deter some patients from opting for intragastric balloon procedures, leading to a slower market growth.

Regional Forecast:

North America:

The Intragastric Balloon market in North America is expected to experience significant growth, particularly in the United States and Canada. The increasing prevalence of obesity and related health issues is driving the demand for non-surgical weight loss solutions such as intragastric balloons. The availability of advanced healthcare infrastructure and increasing awareness about the benefits of intragastric balloons are contributing to market growth in this region.

Asia Pacific:

In the Asia Pacific region, countries such as China, Japan, and South Korea are witnessing a growing demand for intragastric balloons. The rising prevalence of obesity and changing lifestyle habits are driving the adoption of weight loss solutions in these countries. Additionally, advancements in healthcare technology and increasing disposable income are further fueling market growth in the region.

Europe:

The market for intragastric balloons in Europe is strong, especially in countries like the United Kingdom, Germany, and France. The high prevalence of obesity and associated health conditions in these countries is a key factor driving market growth. Additionally, favorable reimbursement policies and increasing focus on preventive healthcare measures are contributing to the rising adoption of intragastric balloons in Europe.

Segmentation Analysis:

In terms of segmentation, the global Intragastric Balloon market is analyzed on the basis of Balloon Type, Filling Material, Administration, End-use.

Intragastric Balloon Market

Single Balloon Type:

The single balloon type segment in the intragastric balloon market is expected to witness significant growth due to its simplicity and effectiveness in promoting weight loss. Single balloons are commonly filled with either saline or gas and can be administered through endoscopy or pill form. They are commonly used in hospitals and ambulatory centers to help patients achieve their weight loss goals.

Dual Balloon Type:

The dual balloon type segment in the intragastric balloon market is growing in popularity due to its ability to provide greater satiety and weight loss benefits compared to single balloons. These balloons are typically filled with saline and are primarily administered through endoscopy. Hospitals and ambulatory centers are key end-users of dual balloons for weight loss interventions.

Triple Balloon Type:

The triple balloon type segment in the intragastric balloon market is relatively new but showing promising results in promoting weight loss. These balloons are usually filled with gas and administered through endoscopy. Hospitals and ambulatory centers are likely to adopt triple balloons for their patients seeking non-surgical weight loss solutions.

Saline Filled Balloons:

Saline filled balloons are the most commonly used filling material in the intragastric balloon market due to their safety profile and effectiveness in promoting weight loss. These balloons can be of single, dual, or triple types and are administered through endoscopy. Hospitals and ambulatory centers prefer saline filled balloons for their weight loss interventions.

Gas Filled Balloons:

Gas filled balloons are gaining traction in the intragastric balloon market, especially in the triple balloon type segment. These balloons offer unique benefits in promoting weight loss and are typically administered through endoscopy. Hospitals and ambulatory centers are likely to adopt gas filled balloons for their weight loss treatments.

Endoscopy Administration:

Endoscopy is the preferred method of administering intragastric balloons in the market due to its precision and safety. Single, dual, and triple balloons filled with saline or gas can be effectively placed using endoscopy. Hospitals and ambulatory centers rely on endoscopy for the successful implementation of intragastric balloon therapy.

Pill Form Administration:

The pill form administration of intragastric balloons is a convenient and non-invasive option for patients seeking weight loss interventions. While currently limited to single balloons filled with saline, pill form administration is expected to gain popularity in the market. Hospitals and ambulatory centers may consider adopting pill form administration for their patients' weight loss needs.

Hospitals End-use:

Hospitals are a key end-user of intragastric balloons in the market, offering weight loss interventions to patients with obesity and related health conditions. Single, dual, and triple balloons filled with saline or gas are commonly used in hospitals for non-surgical weight loss therapies. Endoscopy is the preferred method of administration in hospital settings.

Ambulatory Centers End-use:

Ambulatory centers play a significant role in providing non-surgical weight loss solutions to patients, making them a valuable end-user in the intragastric balloon market. Single, dual, and triple balloons filled with saline or gas can be administered in ambulatory centers through endoscopy. These centers may opt for pill form administration as a convenient option for patients seeking weight loss treatments.

Competitive Landscape:

Competitive landscape in the Intragastric Balloon Market is characterized by intense competition among key players striving to expand their market presence through strategic initiatives such as new product launches, partnerships, and acquisitions. These companies are focused on enhancing their product portfolio and geographical reach to gain a competitive edge in the market.

Top Market Players:

Apollo Endosurgery, Inc.

Allurion Technologies, Inc.

ReShape Lifesciences, Inc.

Obalon Therapeutics, Inc.

ReShape Lifesciences, Inc.

Spatz Medical

Districlass Medical

Life Partners Europe

Endalis

Silimed